F11R

Across TCGA pan-cancer cohorts, F11R mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated F11R data layer compared with 19 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher F11R mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated F11R expression acts as an unfavorable survival marker, although some lineages such as CCRCC and HNSC show a favorable association.

CCRCC, GBM, and HNSC are the cancer types where F11R mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Quartile	II,III,IV	1.000	0.800	.015	13	view →
GBM	OS	Tertile	All	0.386	0.710	.001	12	view →
HNSC	DFS	Quartile	II,III,IV	1.000	0.859	.010	9	view →
PDAC	DFS	Median	IV	0.250	0.934	.024	3	view →
LUAD	DFS	Quartile	II,III,IV	0.821	0.961	.034	2	view →
LSCC	DFS	Tertile	II,III,IV	0.498	1.000	.040	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

F11R–CCRCC (DFS)

Open the CCRCC breakdown →